Capecitabine: all 1,069 studies that test it
Page 5 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PANKU-Breast02)Active, not recruitingNCT06382142Phase 3
- A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)Active, not recruitingNCT06343948Phase 3
- Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer PatientsTerminatedNCT06332079Phase 2
- A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.Active, not recruitingNCT06247995Phase 1/2
- Study of SHR-8068 Combined With Adebrelimab and Platinum-containing Chemotherapy in the Treatment of Advanced Gastric and Esophageal CancerActive, not recruitingNCT06247956Phase 2
- The Therapeutic Effect of Different Doses of CapecitabineCompletedNCT06246461Not applicable
- Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal CancerActive, not recruitingNCT06210971Phase 2
- Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast CancerStatus unknownNCT06156761Not applicable
- Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon CancerActive, not recruitingNCT06124378Phase 2
- A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Active, not recruitingNCT06118333Phase 3
- CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)WithdrawnNCT06110598Phase 2
- Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.CompletedNCT05997524Phase 2
- Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal CancerActive, not recruitingNCT05990543Phase 1/2
- REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity MitigationActive, not recruitingNCT05902533Phase 2/3
- Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer PatientsStatus unknownNCT05833919Phase 2
- Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal CancerCompletedNCT05775900Phase 1/2
- Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast CancerStatus unknownNCT05747326Phase 2
- Galunisertib Combined With Capecitabine in Advanced CRC With PMActive, not recruitingNCT05700656Phase 1/2
- A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer PancreasStatus unknownNCT05566743Phase 2
- Dalpiciclib Plus Letrozole and CapecitabineStatus unknownNCT05469750Phase 2
- A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast CancerStatus unknownNCT05438706Phase 2
- Precise Therapy for Refractory HER2 Positive Advanced Breast CancerStatus unknownNCT05429684Phase 3
- Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant ChemotherapyWithdrawnNCT05415917Phase 2
- Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.Status unknownNCT05411380Phase 2
- A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid TumorsStatus unknownNCT05344742Phase 1
- A Phase II Study of Chiauranib in Combine With Capecitabine in TNBCTerminatedNCT05336721Phase 2
- Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI PatientsStatus unknownNCT05321329Phase 2
- Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWithdrawnNCT05296005Phase 1
- Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract TumorsStatus unknownNCT05291052Phase 2
- Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal CarcinomaWithdrawnNCT05290194Phase 2
- Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)Status unknownNCT05262335Phase 2
- Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialActive, not recruitingNCT05247905Phase 2
- HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric CancerStatus unknownNCT05246982Phase 2
- Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract CancerCompletedNCT05239169Phase 2
- SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
- Margetuximab Plus Tucatinib and Capecitabine in HER2-positive Metastatic Breast CancerWithdrawnNCT05227131Phase 2
- A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast CancerTerminatedNCT05134194Phase 3
- Adaptive Radiation for Locally Advanced Rectal AdenocarcinomaActive, not recruitingNCT05108428Early Phase 1
- Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast CancerStatus unknownNCT05089643Phase 2
- Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast CancerCompletedNCT05064085Phase 1
- PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerCompletedNCT05052437Phase 1
- FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal CancerStatus unknownNCT05018182Phase 2
- Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal CancerStatus unknownNCT05016869Phase 1/2
- Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node MetastasisStatus unknownNCT05002686Phase 2/3
- Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer PatientsCompletedNCT04942626Phase 1
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal CancerActive, not recruitingNCT04929028Phase 2
- Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal CancerActive, not recruitingNCT04922853Phase 3
- TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction AdenocarcinomaActive, not recruitingNCT04891900Not applicable
- A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous ChemotherapyStatus unknownNCT04866108Phase 2
- No Operation After Short Course Radiotherapy Followed By Consolidation Chemotherapy In Locally Advanced Rectal CancerCompletedNCT04864067Phase 2
- A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract TumorsCompletedNCT04861987Phase 1
- Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast CancerStatus unknownNCT04780347Phase 2
- A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast CancerStatus unknownNCT04767828Phase 4
- Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Active, not recruitingNCT04753879Phase 2
- A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)WithdrawnNCT04751955Phase 1/2
- Fruquintinib Plus Capecitabine Versus Bevacizumab Plus Capecitabine as Maintenance Therapy Following First-line Treatment for Metastatic Colorectal CancerStatus unknownNCT04733963Phase 2
- Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.CompletedNCT04720131Phase 2
- Non-OpeRative MANagement of Rectal Cancer PatientsCompletedNCT04696757Phase 2
- A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract CancerStatus unknownNCT04608786Phase 1
- Letrozole and Metronomic Capecitabine in ER-positive HER2 Negative Advanced Breast Cancer (B-001 Study)Status unknownNCT04571437Phase 2
- Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients.Active, not recruitingNCT04564898Phase 1/2
- Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal CancerCompletedNCT04534218Phase 2
- Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric AdenocarcinomaActive, not recruitingNCT04523818Phase 1
- PRECISE CURATE.AI Pilot Clinical TrialStatus unknownNCT04522284Phase 1/2
- A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCCStatus unknownNCT04514835Phase 2
- Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)Status unknownNCT04510818Phase 1
- Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)Status unknownNCT04508686Phase 1
- Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer PatientsCompletedNCT04425564Phase 2
- The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal CancerStatus unknownNCT04411537Phase 2
- The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal CancerStatus unknownNCT04411524Phase 2
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04390958Phase 2
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)Active, not recruitingNCT04383275Phase 2
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Active, not recruitingNCT04379596Phase 2
- Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal CancerCompletedNCT04357587Phase 1
- Molecularly Targeted Umbrella Study in Luminal Advanced Breast CancerStatus unknownNCT04355858Phase 2
- A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric CancerStatus unknownNCT04351867Phase 3
- NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBCActive, not recruitingNCT04335669Phase 3
- Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal CarcinomaStatus unknownNCT04319471Phase 2
- A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGCCompletedNCT04309578Phase 2
- NX in Luminal B Breast Cancer Patients After Neoadjuvant ChemotherapyStatus unknownNCT04307147Phase 3
- Adjuvant Chemotherapy in High Risk Stage II Colon CancerStatus unknownNCT04303429Phase 3
- A Study to Evaluate Vinorelbine Plus Capecitabine Combined With Trastuzumab for HER2 Positive Patients Following Neoadjuvant ChemotherapyStatus unknownNCT04302441Phase 2
- Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal CancerStatus unknownNCT04296240Phase 2
- Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)CompletedNCT04296162Phase 2
- PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After SurgeryActive, not recruitingNCT04295317Phase 2
- Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric AdenocarcinomaCompletedNCT04281576Not applicable
- A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor TherapyTerminatedNCT04274933Phase 1
- Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal CancerActive, not recruitingNCT04262635Phase 3
- Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS TrialActive, not recruitingNCT04259944Phase 2
- Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the BodyActive, not recruitingNCT04248452Phase 3
- Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer PatientsActive, not recruitingNCT04246684Phase 3
- Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast CancerStatus unknownNCT04246502Phase 2
- A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal CancerStatus unknownNCT04227041Phase 1/2
- Study of the Impact of DPD Activity on the Efficacy of CapecitabineActive, not recruitingNCT04198727Phase 2
- Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)Status unknownNCT04188158Phase 2
- Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyActive, not recruitingNCT04166318Phase 2
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal CarcinomaActive, not recruitingNCT04156698Phase 2
- Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal CancerStatus unknownNCT04135313Phase 3
- Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal CancerStatus unknownNCT04134897Phase 3